Concepedia

Publication | Open Access

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

DOIFull Paper Access

352

Citations

15

References

2018

Year

Julie Parmentier, J W Voss, Candace Graff, Annette Schwartz, M.A. Argiriadi, Michael Friedman, Heidi S. Camp, Robert J. Padley, Jonathan S. George, Deborah Hyland,
BMC Rheumatology

Abstract

The data presented here highlight the JAK1 selectivity of upadacinitinib and supports its use as an effective therapy for the treatment of RA with the potential for an improved benefit:risk profile.

References

YearCitations

Page 1